Capital International Inc’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
SIAU
GF
Capital International Inc's VIR Position: Q3 2022 in Review
Capital International Inc sold out of Vir Biotechnology (VIR) in Q3 2022, closing a stake of 14,681 shares — an estimated $374K sold.
Capital International Inc first reported a position in VIR in Q3 2020 and held it in 8 quarters. The position peaked at $3.36M in Q1 2021. 220 funds tracked by Wall St. Rank hold VIR as of Q3 2022.
- Capital International Inc reported no remaining Vir Biotechnology position as of Q3 2022 after selling out during the quarter.
- Capital International Inc sold 14,681 Vir Biotechnology shares in Q3 2022, an estimated $374K.
- Capital International Inc first reported a position in Vir Biotechnology in Q3 2020 and held it in 8 quarters.
- Capital International Inc's Vir Biotechnology position peaked at $3.36M in Q1 2021.
- 220 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2022.
Based on Capital International Inc's 13F filing for Q3 2022, filed 14 Nov 2022.